Home

Připojeno Specializujte se uvážení overall survival Roh Goodwill snap

Kaplan-Meier overall survival curve. The median overall survival was... |  Download Scientific Diagram
Kaplan-Meier overall survival curve. The median overall survival was... | Download Scientific Diagram

ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival
ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival

Overall Survival in Metastatic Breast Cancer Patients in the Third  Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study∗ - Clinical Breast Cancer

Final overall survival results of WJTOG3405, a randomized phase III trial  comparing gefitinib versus cisplatin with docetaxel as the first-line  treatment for patients with stage IIIB/IV or postoperative recurrent EGFR  mutation-positive non-small-cell
Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell

The development and external validation of an overall survival nomogram in  medically inoperable centrally located early-stage non-small cell lung  carcinoma - Radiotherapy and Oncology
The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma - Radiotherapy and Oncology

Overall survival plot. Kaplan–Meier curve is shown for overall survival...  | Download Scientific Diagram
Overall survival plot. Kaplan–Meier curve is shown for overall survival... | Download Scientific Diagram

Predictors of progression free survival, overall survival and early  cessation of chemotherapy in women with potentially platinum sensitive  (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3)  chemotherapy – The GCIG
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG

Significant predictors of overall survival in patients with hepatocellular  carcinoma after surgical resection | PLOS ONE
Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection | PLOS ONE

Objective response by mRECIST as a predictor and potential surrogate  end-point of overall survival in advanced HCC - Journal of Hepatology
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC - Journal of Hepatology

Time Trends of Overall Survival and Survival after Recurrence in Completely  Resected Stage I Non-small Cell Lung Cancer - Journal of Thoracic Oncology
Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer - Journal of Thoracic Oncology

Identification and validation of an epithelial mesenchymal  transition-related gene pairs signature for prediction of overall survival  in patients with skin cutaneous melanoma [PeerJ]
Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma [PeerJ]

The prognostic impact of RAS on overall survival following liver resection  in early versus late-onset colorectal cancer patients | British Journal of  Cancer
The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients | British Journal of Cancer

Final overall survival results from a randomised, phase III study of  erlotinib versus chemotherapy as first-line treatment of EGFR  mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)  - Annals of Oncology
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802) - Annals of Oncology

Correlation of Prostate-specific Antigen Kinetics with Overall Survival and  Radiological Progression-free Survival in Metastatic Castration-sensitive  Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or  Placebos Added to Androgen ...
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...

Circulating inflammation signature predicts overall survival and  relapse-free survival in metastatic colorectal cancer.,British Journal of  Cancer - X-MOL
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.,British Journal of Cancer - X-MOL

Overall survival and cancer-specific survival in patients with surgically  resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis

Validation of an assessment tool: Estimation of Postoperative Overall  Survival for Gastric Cancer - European Journal of Surgical Oncology
Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer - European Journal of Surgical Oncology

A New Nomogram for Predicting Overall Survival and Assisting Postoperative  Adjuvant Treatment Decision-Making in Stage II Oral Tongue Squamous Cell  Carcinoma: A Surveillance, Epidemiology and End Results (SEER) Database  Analysis - Journal
A New Nomogram for Predicting Overall Survival and Assisting Postoperative Adjuvant Treatment Decision-Making in Stage II Oral Tongue Squamous Cell Carcinoma: A Surveillance, Epidemiology and End Results (SEER) Database Analysis - Journal

図11 Overall Survival (Updated)
図11 Overall Survival (Updated)

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC  | NEJM
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM

View Image
View Image

Long-term follow-up of overall survival for cabozantinib versus everolimus  in advanced renal cell carcinoma | British Journal of Cancer
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer

Overall Survival Curve [IMAGE] | EurekAlert! Science News Releases
Overall Survival Curve [IMAGE] | EurekAlert! Science News Releases

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer |  NEJM
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM